Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Pre-Open Movers: lululemon Ramps on Strong Results, PolyPid Sinks on Drug Failure

Published 09/02/2022, 09:22 AM
Updated 09/02/2022, 09:24 AM
© Reuters.  Pre-Open Movers: lululemon Ramps on Strong Results, PolyPid Sinks Drug Failure

Pre-Open Stock Movers

PolyPid (NASDAQ:PYPD) 77% LOWER; Phase 3 SHIELD I trial of D-PLEX100 didn't achieve statistical significance.

HashiCorp Inc (NASDAQ:HCP) 17% HIGHER; post solid Q2 results with revenue rising 52%

Hollysys Automation (NASDAQ:HOLI) 17% HIGHER; a consortium led by the company's management plans to take the company private in a deal that would value the company at $1.8 billion, according to a report.

Lululemon Athletica Inc (NASDAQ:LULU10% HIGHER; reported Q2 EPS of $2.20, $0.34 better than the analyst estimate of $1.86. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.77 billion. lululemon athletica sees Q3 2022 EPS of $1.90-$1.95, versus the consensus of $1.78. lululemon athletica sees Q3 2022 revenue of $1.78-1.805 billion, versus the consensus of $1.73 billion. lululemon athletica sees FY2022 EPS of $9.75-$9.90, versus the consensus of $9.44. lululemon athletica sees FY2022 revenue of $7.865-7.94 billion, versus the consensus of $7.69 billion.

nCino (NASDAQ:NCNO) 8% HIGHER; reported Q2 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $99.6 million versus the consensus estimate of $97.51 million. nCino, Inc. sees Q3 2023 EPS of ($0.02)-($0.03), versus the consensus of ($0.07). nCino, Inc. sees Q3 2023 revenue of $103-104 million, versus the consensus of $101.8 million. nCino, Inc. sees FY2023 EPS of ($0.17)-($0.19), versus the consensus of ($0.29). nCino, Inc. sees FY2023 revenue of $401.5-403.5 million, versus the consensus of $391.5 million.

Broadcom (NASDAQ:AVGO) 4% HIGHER; reported Q3 EPS of $9.73, $0.17 better than the analyst estimate of $9.56. Revenue for the quarter came in at $8.46 billion versus the consensus estimate of $8.41 billion. Broadcom sees Q4 2022 revenue of $8.9 billion, versus the consensus of $8.7 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Oxford Industries (NYSE:OXM) 3% LOWER; reported Q2 EPS of $3.61, $0.14 better than the analyst estimate of $3.47. Revenue for the quarter came in at $363 million versus the consensus estimate of $364 million. Oxford Industries sees Q3 2022 EPS of $9.85-$10.10, versus the consensus of $9.88. Oxford Industries sees Q3 2022 revenue of $1.3-1.325 million, versus the consensus of $1.3 million.

Ooma (NYSE:OOMA) 3% HIGHER; reported Q2 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $52.7 million versus the consensus estimate of $51.66 million. Ooma sees Q3 2023 EPS of $0.11-$0.13, versus the consensus of $0.09. Ooma sees Q3 2023 revenue of $56-56.5 million, versus the consensus of $53.8 million. Ooma sees FY2023 EPS of $0.45-$0.49, versus the consensus of $0.39. Ooma sees FY2023 revenue of $215.5-218.5 million, versus the consensus of $212.04 million.

Ford Motor Company (NYSE:F) 3% HIGHER; August sales rise 27.3 percent.

Okta, Inc (NASDAQ:OKTA) 2% HIGHER; Guggenheim upgraded from Sell to Neutral.

Quanex (NYSE:NX) 2% LOWER; reported Q2 EPS of $0.79, $0.18 better than the analyst estimate of $0.61. Revenue for the quarter came in at $324 million versus the consensus estimate of $300.5 million.

Starbucks (NASDAQ:SBUX) 2% LOWER; announced that Laxman Narasimhan will become the company's next chief executive officer and a member of the Starbucks Board of Directors.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.